http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2011138956-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-36 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2011-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2011138956-A1 |
titleOfInvention | Novel prenylarene compounds and uses thereof |
abstract | General formula (C) (In the formula, R 101 represents a substituted or unsubstituted aromatic heterocyclic group. R 102 , R 103 , R 104 and R 105 are the same or different and each represents a hydrogen atom, a halogen atom, or a carbon atom having 1 to 3 carbon atoms. An alkyl group, a haloalkyl group having 1 to 3 carbon atoms, R 106 represents a hydrogen atom or a saturated or unsaturated hydrocarbon group having a straight chain or branched chain having 1 to 12 carbon atoms, provided that R 101 is 3-furyl group, R 102 , R 103 , R 104 and R 105 are all methyl groups, and R 106 is a methyl group, a 4-methyl-3-pentenyl group, or a 4,8-dimethyl-3,7-nonadienyl group. Except in cases.) Or a pharmaceutically acceptable salt thereof has a hypoxic environment selective growth inhibitory activity in a wide concentration range and is useful as an active ingredient of a preventive or therapeutic agent for cancer. |
priorityDate | 2010-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 308.